NCT05564897 2022-10-04
Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT03827837 2022-07-01
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT03987698 2020-07-07
Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown